Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of CZ012 gel after functional endoscopic sinus surgery
CTR20261909Phase 2Active
- Sponsor
- Cuize Pharma
- Start
- May 2026
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing CZ012 with Placebo (2 arms). Primary endpoint: Lund-Kennedy endoscopic score. Started May 2026; status: active.
02
Drugs
CZ012
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20261909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261909.